Your cart is currently empty!
Abetalipoproteinemia is a rare autosomal recessive disorder caused by a mutation in the gene encoding the microsomal transfer protein (MTP). This condition disrupts the synthesis and secretion of lipoproteins, leading to malabsorption of dietary fats and fat-soluble vitamins.
Aspect | Treatment Strategy |
---|---|
Dietary Modifications | Restriction of long-chain fatty acids. |
Vitamin Supplementation | High doses of oral vitamin E. |
Feature | Details |
---|---|
Genetic Basis | Autosomal recessive, MTP gene mutation. |
Absent Lipoproteins | Chylomicrons, VLDL, LDL. |
Clinical Signs | Fat malabsorption, steatorrhea, failure to thrive, progressive ataxia, retinitis pigmentosa, acanthocytosis. |
Complications | Spinocerebellar degeneration, vitamin E deficiency. |
Diagnosis | Lipid-laden enterocytes on biopsy. |
Treatment | Long-chain fatty acid restriction, oral vitamin E. |
Focus on vitamin E deficiency and its neurological implications, as they are high-yield topics for clinical scenarios related to abetalipoproteinemia.